基于循环胺的全基血型造血细胞移植的移植后移植对瘤的影响
1Department of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Frontiers in immunology
|June 21, 2024
概括
移植后循环胺 (PTCy) 是干细胞移植后预防移植对宿主疾病 (GVHD) 的标准. 需要进行研究,以优化移植与瘤 (GVT) 效应与PTCy一起,以获得更好的患者结果.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 移植后循环胺 (PTCy) 越来越多地用于异构造血细胞移植 (allo-HCT) 中的移植对宿主疾病 (GVHD) 预防.
- PTCy显著影响免疫复原,影响移植后的T细胞和自然杀手细胞功能.
- 基于PTCy的合金HCT后复发率与传统方法相比,突出显示需要增强抗瘤反应.
研究的目的:
- 在基于 PTCy 的 GVHD 预防的背景下,研究移植对瘤 (GVT) 效应.
- 在使用PTCy.时确定维持或诱导GVT效应的策略.
- 通过平衡GVHD控制和抗白血病活性来改善alo-HCT的整体结果.
主要方法:
- 对-HCT中PTCy,GVHD和GVT影响的现有文献的综述.
- 在PTCy给药后对免疫复合模式的分析.
- 对接受PTCy与传统GVHD预防治疗的患者复发率的比较评估.
主要成果:
- 虽然PTCy对GVHD预防有效,但其对GVT效应的影响需要进一步调查.
- 免疫细胞功能和复合被PTCy改变,可能会影响抗瘤免疫力.
- 目前的数据表明,复发发病率相似,但使用PTCy的最佳GVT诱导策略尚未得到充分确立.
结论:
- 对基于PTCy的合金HCT中的GVT效应进行专注研究是非常需要的.
- 与PTCy一起开发增强GVT反应的策略对于改善移植成功至关重要.
- 未来的研究可能涉及新的基于细胞的疗法,以优化GVT的效果,而不会增加GVHD.
更多相关视频
11:55Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
Published on: March 14, 2011
14.6K
06:06Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR
Published on: May 23, 2019
7.1K
相关概念视频
Bone Marrow Sampling and Transplants
324
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
324
Tissue Transplantation
356
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
356
Cell-mediated Immune Responses
68.1K
Overview
68.1K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Tumor Immunotherapy
511
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
511
